261 related articles for article (PubMed ID: 11324777)
1. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study.
Salvarani C; Hunder GG
Arthritis Rheum; 2001 Apr; 45(2):140-5. PubMed ID: 11324777
[TBL] [Abstract][Full Text] [Related]
2. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.
Weyand CM; Fulbright JW; Hunder GG; Evans JM; Goronzy JJ
Arthritis Rheum; 2000 May; 43(5):1041-8. PubMed ID: 10817557
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
Proven A; Gabriel SE; Orces C; O'Fallon WM; Hunder GG
Arthritis Rheum; 2003 Oct; 49(5):703-8. PubMed ID: 14558057
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.
Salvarani C; Cimino L; Macchioni P; Consonni D; Cantini F; Bajocchi G; Pipitone N; Catanoso MG; Boiardi L
Arthritis Rheum; 2005 Apr; 53(2):293-7. PubMed ID: 15818722
[TBL] [Abstract][Full Text] [Related]
6. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
Liozon E; Boutros-Toni F; Ly K; Loustaud-Ratti V; Soria P; Vidal E
J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402
[TBL] [Abstract][Full Text] [Related]
7. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
[TBL] [Abstract][Full Text] [Related]
8. Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature.
Zweegman S; Makkink B; Stehouwer CD
Neth J Med; 1993 Apr; 42(3-4):128-31. PubMed ID: 8316325
[TBL] [Abstract][Full Text] [Related]
9. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.
Cid MC; Font C; Oristrell J; de la Sierra A; Coll-Vinent B; López-Soto A; Vilaseca J; Urbano-Márquez A; Grau JM
Arthritis Rheum; 1998 Jan; 41(1):26-32. PubMed ID: 9433866
[TBL] [Abstract][Full Text] [Related]
10. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.
Proven A; Gabriel SE; O'Fallon WM; Hunder GG
J Rheumatol; 1999 Jun; 26(6):1333-7. PubMed ID: 10381052
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and treatment of giant cell arteritis in Chinese, a prospective study].
Hu Z; Yang Q; Li J; Zeng S; Wu X; Cao L; Yang L; Song X
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):453-5. PubMed ID: 12133513
[TBL] [Abstract][Full Text] [Related]
12. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
13. [Giant cell arteritis and polymyalgia rheumatica: diagnosis and evolution of 90 cases].
Rivero Puente A; Berasategui Calderón JI; Murie Carrillo De Albornoz JM; Rivero Marcotegui M; García-Bragado Acín F
An Med Interna; 2001 Apr; 18(4):191-4. PubMed ID: 11496538
[TBL] [Abstract][Full Text] [Related]
14. [Giant cell arteritis and normal sedimentation rate: more than an exception!].
von Blotzeim SG; Borruat FX
Klin Monbl Augenheilkd; 1996 May; 208(5):397-9. PubMed ID: 8766063
[TBL] [Abstract][Full Text] [Related]
15. Giant cell temporal arteritis with a normal erythrocyte sedimentation rate: report of a case.
Ciccarelli M; Jeanmonod D; Jeanmonod R
Am J Emerg Med; 2009 Feb; 27(2):255.e1-3. PubMed ID: 19371556
[TBL] [Abstract][Full Text] [Related]
16. Giant-cell arteritis in the southern United States. An 11-year retrospective study from the Texas Gulf Coast.
Gonzalez EB; Varner WT; Lisse JR; Daniels JC; Hokanson JA
Arch Intern Med; 1989 Jul; 149(7):1561-5. PubMed ID: 2742429
[TBL] [Abstract][Full Text] [Related]
17. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
Nesher G; Berkun Y; Mates M; Baras M; Rubinow A; Sonnenblick M
Arthritis Rheum; 2004 Apr; 50(4):1332-7. PubMed ID: 15077317
[TBL] [Abstract][Full Text] [Related]
18. Plasma viscosity in giant cell arteritis.
Finke C; Schroeter J; Kalus U; Ploner CJ
Eur Neurol; 2011; 66(3):159-64. PubMed ID: 21894018
[TBL] [Abstract][Full Text] [Related]
19. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population.
Gonzalez-Gay MA; Garcia-Porrua C; Amor-Dorado JC; Llorca J
Arthritis Rheum; 2004 Aug; 51(4):652-5. PubMed ID: 15334440
[TBL] [Abstract][Full Text] [Related]
20. Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency.
Durkin SR; Athanasiov PA; Crompton JL
Aust Fam Physician; 2006 Nov; 35(11):889-91. PubMed ID: 17099810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
